Thu, April 19, 2012
Wed, April 18, 2012
Tue, April 17, 2012
Mon, April 16, 2012
Sun, April 15, 2012
[ Sun, Apr 15th 2012 ] - Market Wire
DaVita Announces CFO Transition
Sat, April 14, 2012
Fri, April 13, 2012
Thu, April 12, 2012
Wed, April 11, 2012
Tue, April 10, 2012
Mon, April 9, 2012
Fri, April 6, 2012
Thu, April 5, 2012
[ Thu, Apr 05th 2012 ] - Market Wire
April 30, 2012
Wed, April 4, 2012

Cumberland Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 3, 2012


//health-fitness.news-articles.net/content/2012/ .. uarter-2012-financial-results-on-may-3-2012.html
Published in Health and Fitness on Thursday, April 12th 2012 at 13:11 GMT by Market Wire   Print publication without navigation


Cumberland Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 3,... -- NASHVILLE, Tenn., April 12, 2012 /PRNewswire/ --

Cumberland Pharmaceuticals to Announce First Quarter 2012 Financial Results on May 3, 2012

[ ]

NASHVILLE, Tenn., April 12, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: [ CPIX ]) announced today that it will release its first quarter 2012 results after the market closes on Thursday, May 3, 2012.  A conference call and live Internet webcast will be held on Thursday, May 3, 2012, at 5:00 p.m. Eastern Time to discuss the results.

To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers).  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers).  The Conference ID for the rebroadcast is 70848539. The live webcast and rebroadcast can be accessed via Cumberland's website at [ http://investor.shareholder.com/cpix/events.cfm ].

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on Cumberland, please visit the Company's website at [ www.cumberlandpharma.com ].

SOURCE Cumberland Pharmaceuticals Inc.

[ Back to top ]

RELATED LINKS
[ http://www.cumberlandpharma.com ]


Publication Contributing Sources